Pramipex ER 0.375 Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Pramipexole (0.375mg)
Overview Pramipex ER 0.375 Tablet
Extended-release pramipexole 0.375mg tablets are indicated for managing Parkinson's disease and restless legs syndrome, characterized by an irresistible urge to move one's legs often stemming from unpleasant sensations. This medication mitigates excessive tremors by regulating movement. Administer this tablet with food, consistently at the same time daily for optimal therapeutic blood levels. Follow your physician's prescribed dosage and regimen; if a dose is missed, take it immediately upon recollection. Complete the full course of therapy as directed, even with symptom improvement; abrupt cessation is contraindicated without prior medical consultation. Potential adverse effects include nausea, xerostomia, weariness, visual or auditory hallucinations, bowel irregularity, and peripheral swelling. Drowsiness and vertigo are also possible; refrain from operating machinery or engaging in activities demanding concentration until the drug's impact is understood. Report any atypical mood shifts, heightened libido, compulsive gambling, or excessive spending to your doctor promptly, as these may indicate serious complications.
Primary Ingredients of Pramipex ER 0.375 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Pramipex ER 0.375 Tablet
Tremors and involuntary movements associated with Parkinson's disease and restless legs syndrome.
Major Benefits of Pramipex ER 0.375 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The Pramipex ER 0.375mg tablet should be administered with food.
Common Side effects of Pramipex ER 0.375 Tablet:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Pramipex ER 0.375 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pramipex ER 0.375mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
How Pramipex ER 0.375 Tablet works:
Pramipexole extended-release 0.375 mg tablets function by imitating the effects of dopamine, a neurotransmitter crucial for regulating motor control within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Taking Pramipexole ER 0.375 mg tablets with alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Pramipex ER 0.375 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Pramipex ER 0.375mg tablets while breastfeeding is likely unsafe. Available data in humans indicates potential transfer to breast milk, posing a risk to the infant. This medication's prolactin-suppressing effect can negatively impact lactation.
DrivingUNSAFE
Driving ability may be impaired by Pramipex ER 0.375 mg tablets, which can induce hallucinations—perceptual distortions such as seeing, hearing, or feeling nonexistent stimuli.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Pramipexole ER 0.375 mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Pramipexole ER 0.375 mg tablets appear to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Pramipex ER 0.375 Tablet :
Omit any missed Pramipex ER 0.375 mg tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pramipex ER 0.375 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzothiazole compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Dopamine-stimulating medications |





